Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May 17:10:e69192.
doi: 10.7554/eLife.69192.

Danger zone

Affiliations
Comment

Danger zone

Zohra Butt et al. Elife. .

Abstract

What level of Ras genes activity leads to the development of cancer?

Keywords: RAS; cancer biology; carcinogenesis; codon bias; mouse; oncogenesis; tumor initiation; tumour initiation.

PubMed Disclaimer

Conflict of interest statement

ZB, IP No competing interests declared

Figures

Figure 1.
Figure 1.. Optimal Ras signalling is required for tumour development.
Li and Counter investigated the impact of Q61* and G12* mutations in the Ras gene KRAS on wild-type and mutant mice. Q61* and G12* mutations respectively lead to a large and moderate increase in the activity of the gene. Wild-type mice exposed to urethane (which causes Q61* mutations) develop lung cancer after a year (top; first line of table). KRASex3op mutant mice have raised Ras activity, and therefore increased oncogenic stress; in these animals, the G12* mutation is the main driver of tumours, because it is less active than Q61* (second line of table). Conversely, p53-/- mice have decreased oncogenic stress and are able to tolerate high levels of Ras activity driven by Q61* mutations, leading to tumour growth; however, they also showed increased levels of G12* KRAS mutant messenger RNA (third line). p53-/-, KRASex3op mutants have normal levels of oncogenic stress, and in these animals both Q61* and G12* mutation can lead to disease (fourth line). Overall, depending on the genetic background of the animal, which mutations lead to the level of Ras activity that triggers cancer varies (bottom). ↑ indicate genotypes or post-transcriptional mechanisms that increase Ras abundance.

Comment on

References

    1. Burd CE, Liu W, Huynh MV, Waqas MA, Gillahan JE, Clark KS, Fu K, Martin BL, Jeck WR, Souroullas GP, Darr DB, Zedek DC, Miley MJ, Baguley BC, Campbell SL, Sharpless NE. Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma. Cancer Discovery. 2014;4:1418–1429. doi: 10.1158/2159-8290.CD-14-0729. - DOI - PMC - PubMed
    1. Burgess MR, Hwang E, Mroue R, Bielski CM, Wandler AM, Huang BJ, Firestone AJ, Young A, Lacap JA, Crocker L, Asthana S, Davis EM, Xu J, Akagi K, Le Beau MM, Li Q, Haley B, Stokoe D, Sampath D, Taylor BS, Evangelista M, Shannon K. KRAS allelic imbalance enhances fitness and modulates MAP kinase dependence in Cancer. Cell. 2017;168:817–829. doi: 10.1016/j.cell.2017.01.020. - DOI - PMC - PubMed
    1. Dwyer-Nield LD, McQuillan J, Hill-Baskin A, Radcliffe RA, You M, Nadeau JH, Malkinson AM. Epistatic interactions govern chemically-induced lung tumor susceptibility and Kras mutation site in murine C57BL/6J-ChrA/J chromosome substitution strains. International Journal of Cancer. 2010;126:125–132. doi: 10.1002/ijc.24743. - DOI - PMC - PubMed
    1. Haigis KM, Cichowski K, Elledge SJ. Tissue-specificity in cancer: the rule, not the exception. Science. 2019;363:1150–1151. doi: 10.1126/science.aaw3472. - DOI - PubMed
    1. Killoran RC, Smith MJ. Conformational resolution of nucleotide cycling and effector interactions for multiple small GTPases determined in parallel. Journal of Biological Chemistry. 2019;294:9937–9948. doi: 10.1074/jbc.RA119.008653. - DOI - PMC - PubMed

LinkOut - more resources